Computational drug repositioning based on multi-similarities bilinear matrix factorization

Author:

Yang Mengyun1,Wu Gaoyan1,Zhao Qichang1,Li Yaohang2,Wang Jianxin1

Affiliation:

1. School of Computer Science and Engineering, Central South University, China

2. Old Dominion University, USA

Abstract

Abstract With the development of high-throughput technology and the accumulation of biomedical data, the prior information of biological entity can be calculated from different aspects. Specifically, drug–drug similarities can be measured from target profiles, drug–drug interaction and side effects. Similarly, different methods and data sources to calculate disease ontology can result in multiple measures of pairwise disease similarities. Therefore, in computational drug repositioning, developing a dynamic method to optimize the fusion process of multiple similarities is a crucial and challenging task. In this study, we propose a multi-similarities bilinear matrix factorization (MSBMF) method to predict promising drug-associated indications for existing and novel drugs. Instead of fusing multiple similarities into a single similarity matrix, we concatenate these similarity matrices of drug and disease, respectively. Applying matrix factorization methods, we decompose the drug–disease association matrix into a drug-feature matrix and a disease-feature matrix. At the same time, using these feature matrices as basis, we extract effective latent features representing the drug and disease similarity matrices to infer missing drug–disease associations. Moreover, these two factored matrices are constrained by non-negative factorization to ensure that the completed drug–disease association matrix is biologically interpretable. In addition, we numerically solve the MSBMF model by an efficient alternating direction method of multipliers algorithm. The computational experiment results show that MSBMF obtains higher prediction accuracy than the state-of-the-art drug repositioning methods in cross-validation experiments. Case studies also demonstrate the effectiveness of our proposed method in practical applications. Availability: The data and code of MSBMF are freely available at https://github.com/BioinformaticsCSU/MSBMF. Corresponding author: Jianxin Wang, School of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, P. R. China. E-mail: jxwang@mail.csu.edu.cn Supplementary Data: Supplementary data are available online at https://academic.oup.com/bib.

Funder

National Natural Science Foundation of China

Graduate Research Innovation Project of Hunan

Hunan Provincial Science and Technology Program

111Project

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference59 articles.

1. New uses for old drugs;Chong;Nature,2007

2. Drug development: from concept to marketing!;Tamimi;Nephron Clin Pract,2009

3. Challenges and opportunities of drug repositioning;Novac;Trends Pharmacol Sci,2013

4. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat Rev Drug Discov,2019

5. Biomedical data and computational models for drug repositioning: a comprehensive review;Luo;Brief Bioinform,2020

Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hierarchical Semantic Augmentation Graph Neural Network for Drug-Disease Association Prediction;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

2. Effective Drug Repositioning with a Novel Negative Sample Selection Algorithm;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

3. Enhancing Drug Repositioning through Contrastive Learning and Denoised Negative Sampling;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

4. A Graph Deep Learning-Based Framework for Drug-Disease Association Identification with Chemical Structure Similarities;Journal of Computational Biophysics and Chemistry;2023-11-23

5. A simplified similarity-based approach for drug-drug interaction prediction;PLOS ONE;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3